| Authors: |
Dave NK; Department of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Carvajal V; Department of Hematology and Oncology, Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Watts AC; Department of Hematology and Oncology, Center for Clinical Epidemiology and Biostatistics, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Carter JS; Department of Hematology and Oncology, Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Cook M; Department of Hematology and Oncology, Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Thomas C; Department of Hematology and Oncology, Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Tsai DE; Department of Hematology and Oncology, Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Schuster SJ; Department of Hematology and Oncology, Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Gerson JN; Department of Hematology and Oncology, Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Barta SK; Department of Hematology and Oncology, Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Svoboda J; Department of Hematology and Oncology, Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Chong EA; Department of Hematology and Oncology, Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Hwang WT; Department of Hematology and Oncology, Center for Clinical Epidemiology and Biostatistics, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Landsburg DJ; Department of Hematology and Oncology, Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Nasta SD; Department of Hematology and Oncology, Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA. |
